Journals / Cyprus Journal of Medical Sciences / 2020 / Cilt: 5 - Sayı: 2

Some Aspects of Stem Cell Therapy

Pages
183–185
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Obviously, therapeutic methods with unproven effects should be applied within the framework of sound research shielded from the funding bias.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This short report is an overview of recent literature on stem cells and cell therapies.
📊
Key Findings & Data:Certain papers tend to exaggerate positive effects leaving adverse events out of attention.
💡
Conclusion & Impact:Obviously, therapeutic methods with unproven effects should be applied within the framework of sound research shielded from the funding bias.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

This short report is an overview of recent literature on stem cells and cell therapies. Certain papers tend to exaggerate positive effects leaving adverse events out of attention. Therefore, conclusions are partly based here on theoretic considerations. There is a discrepancy between the supposed ability of exogenous stem cells to migrate and engraft in tissues, differentiate along various cell lineages, and the absence of clear morphological evidence in vivo. Some papers discuss rejuvenation, replacement of senescent and damaged cells; others explain reported beneficial effects by paracrine or immunomodulating mechanisms. There are no prima facie reasons to assume that paracrine functions are more developed in morphologically primitive SC than in more mature cells. Stem cells are a promising field of research; however, studies of differentiated cells and cell-free products mimicking paracrine effects of cell therapies may be promising as well. Obviously, therapeutic methods with unproven effects should be applied within the framework of sound research shielded from the funding bias.

🔖

Cite This Article

JARGIN, S. V. (2020). Some Aspects of Stem Cell Therapy. Cyprus Journal of Medical Sciences, Cilt: 5 - Sayı: 2, 183–185. https://ajindex.com/articles/149509

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Jargin SV. Drugs and dietary supplements with unproven effects in research and practice. J Complement Med Res 2019
  2. 10(1): 27-7. [Crossref] 2. Jargin SV. Hormesis: Umbrella mechanism only for agents present in the environment. Hum Exp Toxicol 2015
  3. 34(4): 439-41. [Crossref] 3. Jargin SV. Development of antiatherosclerotic drugs on the basis of cell models: A comment. Int J Pharmacol Phytochem Ethnomed 2015
  4. [Crossref] 4. Jargin SV. Glycosaminoglycans and their precursors in osteoarthritis. Open Veterinary Journal 2018. Available From: URL: https://www.openveterinaryjournal.com/OVJ-Letter-7-1-2018-S.V.%20Jargin.pdf 5. Lau A, Kennedy BK, Kirkland JL, Tullius SG. Mixing old and young: enhancing rejuvenation and accelerating aging. J Clin Invest 2019
  5. 129(1): 4-11. [Crossref] 6. Nguyen N, Sussman MA. Rejuvenating the senescent heart. Curr Opin Cardiol 2015
  6. 30(3): 235-9. [Crossref] 7. Neves J, Sousa-Victor P, Jasper H. Rejuvenating strategies for stem cell-based therapies in aging. Cell Stem Cell 2017
  7. 20(2): 161-75. [Crossref] 8. Blum B, Benvenisty N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 2009
  8. 8(23): 3822-30. [Crossref] 9. Lin FC, Chen WP, Chu PH, Shyu KG, Wen MS. Current status and perspectives in stem cell therapy for heart. Acta Cardiol Sin 2014
  9. 30(5): 382-94. 10. Jargin SV. Stem cells and cell therapy. Cardiology 2010
  10. 117(3): 198. [Crossref] 11. Jargin SV. Stem cells and cell therapy: on the eve of scientific discovery. Cell Tissue Biol 2011
  11. [Crossref] 12. ter Horst K.W. Stem cells and cell Therapy: popular belief? Cardiology 2010
  12. 117(3): 199. [Crossref] 13. Tang JN, Cores J, Huang K, Cui XL, Luo L, Zhang JY, et al. Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future. Stem Cells Transl Med 2018
  13. 7(4): 354-9. [Crossref] 14. Elnakish MT, Hassan F, Dakhlallah D, Marsh CB, Alhaider IA, Khan M. Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int 2012
  14. 646038. [Crossref] 15. Jaquet K, Krause KT, Denschel J, Faessler P, Nauerz M, Geidel S, et al. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? Stem Cells Dev 2005
  15. 14(3): 299-309. [Crossref] 16. Le T, Chong J. Cardiac progenitor cells for heart repair. Cell Death Discov 2016
  16. 16052. [Crossref] 17. Suncion VY, Ghersin E, Fishman JE, Zambrano JP, Karantalis V, Mandel N, et